USA shifts policy, sends $600 million to GAVI; Trump's funding freeze ends

The United States has reversed a funding freeze initiated under the Trump administration and committed $600 million to GAVI, the Vaccine Alliance. This policy shift restores U.S. support for global immunization programs, particularly in low-income countries. The decision was announced by the Biden administration, marking a return to vaccine diplomacy. GAVI relies on donor funding to procure and distribute vaccines for diseases such as measles, polio, and COVID-19. The $600 million pledge is a significant portion of GAVI's current replenishment cycle. The move signals a renewed U.S. commitment to multilateral health initiatives.

Global Impact

Politically, the U.S. return to GAVI reinforces its role in global health governance, countering Chinese and Russian influence in vaccine diplomacy. Economically, the $600 million injection supports GAVI's 2021-2025 strategy, potentially immunizing 300 million children and averting 7-8 million future deaths.